Sol Langermann - 29 Mar 2024 Form 4 Insider Report for NextCure, Inc. (NXTC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXTC	Employee Stock Option (Right to Buy)	Award	$0	+93,900		$0.000000	93,900	29 Mar 2024	Common Stock	93,900	$2.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in full on the one year anniversary of the grant, March 29, 2025.